Advances in radiation oncology 2022 Dec 24
Management of Adverse Radiation Effect Associated with Stereotactic Radiosurgery of Brain Metastasis in Multiple Sclerosis.
Related Questions
New answer by Medical Oncologist at Honor Health Neuroscience (February 6, 2024)
I agree with Dr. @Stea. I would consider systemic treatment with Bevacizumab/temozolomide (Park regimen) with temozolomide 150 mg/m2 orally on days 1-7 and days 15-21 and...